Glerelin 22.5Mg Inj

Glerelin 22.5Mg Inj belongs to the class of 'anticancer or anti-neoplastic agents', primarily used to treat prostate cancer in men, breast cancer and endometriosis in women and precocious puberty (early puberty) in children. Prostate cancer is the prostate gland's cancer (a small gland under the bladder secretes fluid that nourishes and protects sperm) found only in men. Breast cancer is a type of cancer that develops in breast cells stimulated by a female sex hormone called oestrogen. Endometriosis is a disorder in which tissue lining the uterus grows outside the uterine cavity. Precocious puberty occurs when a child's body changes into that of an adult or experiences puberty too soon.

Glerelin 22.5Mg Inj contains Leuprolide that belongs to the class of gonadotropin-releasing hormone (GnRH) agonists. It is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. It works by inhibiting the synthesis of the natural male hormone, testosterone in men and oestrogen in women. This process of lowering hormone levels can decrease cancer cell's growth in prostate cancer in men and shrinks endometriosis and breast cancer in women.

Take Glerelin 22.5Mg Inj as prescribed by your doctor. Your doctor will decide the dosage depending on your medical condition. The common side effects of Glerelin 22.5Mg Inj include hot flashes, decreased sexual interest, shrinking of the testicles, breast tenderness or swelling, dizziness, headache, nausea, vomiting, diarrhoea, upset stomach and injection site pain reaction. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.

To treat your condition effectually continue taking Glerelin 22.5Mg Inj for as long as your doctor has prescribed. Do not stop Glerelin 22.5Mg Inj midway.  Avoid taking Glerelin 22.5Mg Inj if you are pregnant or breastfeeding because this Glerelin 22.5Mg Inj can cause harmful effects on the unborn baby. Both women and men using this Glerelin 22.5Mg Inj should use birth control to avoid pregnancy. Glerelin 22.5Mg Inj may also affect fertility in men, hence discuss with your doctor if you have any plans to start a family in the future. Glerelin 22.5Mg Inj is not recommended for children below two years of age. Glerelin 22.5Mg Inj may make you feel dizzy, hence drive when you are alert only.

Glerelin 22.5Mg Inj contains Leuprolide, a gonadotropin-releasing hormone (GnRH) agonist. It treats prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. Glerelin 22.5Mg Inj is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. Being an anti-neoplastic or anticancer agent, Glerelin 22.5Mg Inj works by lowering testosterone levels in men that help stop the growth of cancer cells in prostate cancer. Glerelin 22.5Mg Inj reduces oestrogen (a hormone required for the development and regulation of the female reproductive system and secondary sexual characteristics) levels in women, thus helps in shrinking of endometriosis and breast cancer.

• Weight changes
• Hot flushes
• Muscle weakness
• Bone Pain
• Loss of interest in sexual intercourse
• Inability to have an erection
• Tiredness
• Difficulty sleeping
• Headaches
• Breast tenderness
• Changes in breast size
• Mood swings
• Abdominal pain
• Vomiting (feeling sick)
• Acne
• Vaginal Bleeding 
• Spotting
• Injection site reactions (skin hardening, redness, pain, abscesses, swelling, nodules, ulcers and skin damage)

If you are allergic to Glerelin 22.5Mg Inj or any other medicines, please tell your doctor. Glerelin 22.5Mg Inj can affect the unborn baby when used in pregnancy. Hence, Glerelin 22.5Mg Inj is not indicated for use in pregnancy and breastfeeding women. If you are using Glerelin 22.5Mg Inj, make sure to use reliable forms of contraception to prevent pregnancy during the course. Glerelin 22.5Mg Inj may also affect fertility in men, hence discuss with your doctor if you have any plans to start a family in the future. Use the Glerelin 22.5Mg Inj with caution in elderly patients and children. Glerelin 22.5Mg Inj is not recommended for children younger than two years of age. Your symptoms may become temporarily worse when you first start taking Glerelin 22.5Mg Inj. Inform your doctor if this continues for longer than 2 months. If you have a seizure or unusual changes in mood or behaviour, inform your doctor immediately. Before starting Glerelin 22.5Mg Inj, let your doctor know if you have any medical history of liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Glerelin 22.5Mg Inj may cause QT prolongation (heart muscle takes longer than normal to recharge between beats) and may affect heart rhythm, hence heart patients should be cautious while taking Glerelin 22.5Mg Inj. Glerelin 22.5Mg Inj can make you feel dizzy and affects your mental ability to drive. Do not drive or operate machinery if you are not mentally alert and focused.

• QUINIDINE
• PROCAINAMIDE
• DISOPYRAMIDE
• AMIODARONE
• DEXAMETHASONE
• METHYLPREDNISOLONE
• PREDNISOLONE
• MOXIFLOXACIN
• METHADONE
• CITALOPRAM
• ESCITALOPRAM
• FLUOXETINE
• FLUVOXAMINE
• PAROXETINE
• SERTRALINE

• Your doctor may advise liver function tests to monitor your liver health since Glerelin 22.5Mg Inj may cause increased liver enzymes (alanine aminotransferase, serum aspartate and serum transaminases).
• Glerelin 22.5Mg Inj may cause increased serum glucose levels (hyperglycaemia), hence inform your doctor if you have diabetes before starting Glerelin 22.5Mg Inj.
• Your doctor may advise blood tests, electrolyte levels and regular examinations of the prostate.
• It is advised to get an electrocardiogram (ECG) done timely to monitor your heart health.

• Take the medication as directed by the doctor and at regular intervals. 
• Maintain a fibre-rich diet and include healthy carbohydrates from fruits, vegetables and whole grains.
• Include fish, soy, tomatoes, Brussels sprouts, kale, broccoli and oils containing omega-3 fatty acids such as olive oil as these foods may reduce the risk of prostate cancer.
• Avoid grilled meat, red meat, saturated fat found in animal products, milk and dairy products.
• Exercise regularly to lose weight as obesity is also considered a risk factor for prostate cancer.
• Eat at regular intervals.
• Keep your weight under control with BMI 19.5-24.9.
• Opt for a diet rich in whole grains, fruits, veggies and low-fat dairy products.